The protozoan parasite Trypanosoma cruzi is the aetiologic agent of Chagas' disease, which is one of the most significant human health problems in South and Central America (Lima et al. 2010) . Only two therapeutic options for Chagas' disease, benznidazole and nifurtimox, have been available for over 40 years. These drugs are primarily effective during the early-acute phase; in chronically infected patients, they are considered less effective and their use can even lead to resistance. The severe side effects associated with benznidazole and nifurtimox and the absence of paediatric formulations (a serious issue because the majority of acute Chagas disease patients are children) underscore the drawbacks of these drugs (Canavaci et al. 2010 ). The characterisation of T. cruzi-specific molecules or processes could provide a basis for the development of novel tools for appropriate disease treatments.
The T. cruzi life cycle comprises at least four stages: in the triatomine insect, the epimastigote differentiates into the metacyclic trypomastigote, which can invade a mammalian host and transform into the replicative intracellular amastigote. The amastigote stage ultimately differentiates into the trypomastigote bloodstream form, which destroys the cell and propagates the infection by invading more host cells (Lima et al. 2010) . The mechanisms that regulate these differentiation steps remain poorly understood (Martinez-Calvillo et al. 2010 ). Because there appears to be virtually no regulation of transcription initiation for protein-coding genes in T. cruzi, the regulation of their expression is thought to depend mainly on post-transcriptional processes (Clayton & Shapira 2007 , Haile & Papadopoulou 2007 . The mature mRNAs are derived from polycistronic transcripts that are produced at relatively constant levels (except for occasional genomic copy amplification) and are regulated at the level of degradation, localisation or translation via untranslated region signals and RNA-binding proteins (Kramer & Carrington 2011) . Several of the T. cruzi regulatory proteins have been identified; however, the mechanisms governing the developmental differentiation process of the parasite remain largely unknown (Araujo & Teixeira 2011) .
We previously identified a 17-kDa RNA-binding protein, TcRBP19, that is exclusive to trypanosomatids and is differentially expressed during the life cycle of T. cruzi, being detected only in the amastigote stage (PerezDiaz et al. 2007 ). The RNA-binding domain of TcRBP19 belongs to the RNA-recognition motif family (RRM), which is widely represented in proteins involved in posttranscriptional events, such as RNA processing, transport, translation, degradation and stabilisation (Dreyfuss et al. 2002) . In the T. cruzi genome, 77 open reading frames that code for putative RRM-containing proteins have been identified (De Gaudenzi et al. 2005) ; however, with few exceptions, the expression and functional roles of these proteins remain to be characterised (D'Orso & Frasch 2002 , De Gaudenzi et al. 2003 , Noe et al. 2008 , Cassola & Frasch 2009 . The low levels of TcRBP19 expression, together with its ability to discriminate between RNA targets, led us to propose the involvement of this protein in specific regulatory steps of gene expression (Perez-Diaz et al. 2007) .
Because no functional RNA interference mechanism has been demonstrated in T. cruzi (da Rocha et al. 2004) and only a few cases of gene knockdown have been reported, overexpression constitutes the major approach to address functional roles in this parasite. Therefore, we studied the phenotypic changes resulting from TcRBP19 overexpression during the T. cruzi life cycle. In this study, we present a comparative analysis of the in vitro Key words: differentiation -metacyclogenesis -amastigogenesis differentiation of epimastigotes of T. cruzi Dm28 clone into metacyclic trypomastigotes and amastigotes using pTEX-TcRBP19 and control pTEX transfectants.
The transfectant epimastigotes were maintained at 28ºC in a liver infusion tryptose medium supplemented with 10% heat-inactivated foetal bovine serum and 250 µg/mL G-418 to provide selective pressure to maintain a low plasmid copy number in the transfected population. Polymerase chain reaction (PCR) with vector primers and western blotting with a specific anti-TcRBP19 antibody (Perez-Diaz et al. 2007 ) were done for confirmation of transfectant population. An average overexpression level of approximately 1 ng of TcRBP19 per µg of total protein extract was estimated using western ) were used to analyze overexpression in cellular amastigotes relative to gapdh used as a housekeeping mRNA (lpgapdh1 5'-CGACAACGAGTGGGGATACT-3' and lpgapdh2 5'-CTACAACCTTGCCGAACGAT-3' primers). Each point corresponds to the average obtained from quadruplicates corresponding to the two independent plasmid transfection (pTEX-TcRBP19 A and B) and to the control (pTEX). Results are expressed as means ± standard deviation. Normality and homogeneity were evaluated by analysis of variance (ANOVA). t-test was used to determine the statistical significance (*) difference (**p < 0.0001); B: percentage of infected VERO cells using TcRBP19 overexpressing parasites. The two independent transfectant are indicated in gray (pTEX-TcRBP19 A) and black (pTEX-TcRBP19 B), respectively, and the pTEX transfectant control in white. Assays were done in quadruplicates and 300 cells were counted in each experiment. Normality and homogeneity data were evaluated by ANOVA. Tukey's test was used to determine the statistical significance. (*) difference (*p < 0.05); C: representative images of infected VERO cells. Monolayers were infected with pTEX (a-c) and pTEX-TcRBP19-A (d-f) transfectants at different incubation times. VERO cells were infected with metacyclic forms of the transfectant parasites (pTEX or pTEX-TcRBP19) (1:10). After 24 h of infection, the infected monolayers were cultured with daily medium changes. Cultures were followed by optical microscopy. Arrows point to the intracellular forms of the transfectants. Original magnification: 1.000X.
blotting. Metacyclic trypomastigotes were prepared and purified in diethylaminoethyl cellulose columns (Condiethylaminoethyl cellulose columns (Concolumns (Contreras et al. 1985) and were then used to infect VERO or HeLa cells in a 10:1 parasite:mammalian cell ratio. The trypomastigote motility was checked using optical microscopy prior to infection. The infected monolayers were cultured in RPMI medium (Sigma) at 37ºC without shaking in a 5% CO 2 atmosphere for four days, with a daily medium change beginning 24 h after infection. Immunoflourescent assay was used to confirm TcRBP19 overexpression during the different parasite life cycle stages. The results of quantitative reverse transcription-PCR revealed a 475-fold increase in tcrbp19 mRNA in the TcRBP19-overexpressing amastigotes compared with the pTEX control parasites (Fig. 1A) . In a previous study, we found no phenotypic differences between epimastigotes ectopically overexpressing TcRBP19 and control transfectants carrying the empty vector (PerezDiaz et al. 2007 ).
Regarding metacyclogenesis, we found that the ectopic overexpression of TcRBP19 produced a reduction of the metacyclic stage yield. Indeed, although 40% of the cells transfected with the pTEX control vector differentiated into metacyclic trypomastigotes, only 26-28% of the pTEX-TcRBP19 transfectants underwent a similar differentiation (Table) .
In contrast, there were no significant differences between the pTEX-TcRBP19 transfectants and the controls in terms of the mean numbers of intracellular amastigote parasites per infected cell (Table) . However, at all the analysed time points, the percentage of infected VERO cells was significantly lower for the pTEX-TcRBP19 transfectants compared with the pTEX control-transfected parasites (Fig. 1B) . Therefore, TcRBP19 overexpression at the intracellular stage of T. cruzi life cycle, in which the protein is usually present, neither introduced obvious phenotypic changes nor affected the replication ability. However, the cellular infectivity of the trypomastigotes that ectopically overexpressed TcRBP19 was reduced. Fig. 1C shows representative images of the infectivity of the control pTEX (a-c) and pTEX-TcRBP19 (d-f) transfectants at different incubation times. Consistent results were obtained for two independent pTEXTcRBP19 transfections.
HeLa cells were also infected with these parasites. Whereas 37% of the HeLa cells became infected using the pTEX transfectants, only 8% were infected when the pTEX-TcRBP19 transfectants were used. Thus, similar reductions in the infection efficiency of parasites overexpressing TcRBP19 were observed in two different host cell lines. It is worth mentioning that we previously used an identical approach to characterise the RNA-binding protein TcPuf6. In that case, no effects on either metacyclogenesis or amastigogenesis were observed (Dallagiovanna et al. 2008) . The data presented here suggest that the ectopic overexpression of TcRBP19 affects the successful differentiation of epimastigotes into the infective metacyclic form (Fig. 2) .
The reduced yield of metacyclic pTEX-TcRBP19 trypomastigotes compared with the pTEX-transfected parasite yield led us to hypothesise that either the ability to interpret and/or respond to the mechanisms triggered by nutritional stress signals or the differentiation process itself may be affected by the ectopic expression of TcRBP19. Modifying the levels of this RNA-binding protein may produce imbalances in the gene regulatory networks that facilitate the life cycle progression of the T. cruzi parasite.
Moreover, the reduction in the number of infected mammalian cells caused by TcRBP19 overexpression constitutes further evidence of a regulatory role for this protein. The identification of target genes whose expression is regulated by TcRBP19 and the roles of these genes in the mechanisms of infection, cell adherence and/or invasion require further research.
The data presented here indicate that the control of TcRBP19 expression is required to achieve completely efficient metacyclogenesis and productive infection.
These findings, together with the observation that TcRBP19 orthologues are present only in trypanosomatids (Perez-Diaz et al. 2007) , support the importance of pursuing further the analysis and characterisation of this RNA-binding protein as a potential tool in the fight against trypanosomatid illnesses. The identification and characterisation of factors involved in the regulation of differentiation and infection could also enhance our understanding of the parasite-host interaction and distinctive molecular processes. 
